Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02863692 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of the German CLL Study Group

Study acronym: CLL-Registry
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv13
  2. Minor Publications: 2 to 3v12
  3. Notable Primary and study completion dates: Dec 2025 to Dec 2026v11
  4. Minor Re-verified, no change to tracked fieldsv10
  5. Notable Enrollment target: 3000 to 8000v9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Publications: details revised at 1 of 2 entriesv8
  2. Notable Primary completion date: Dec 2020 to Dec 2025v7
  3. Minor 4 versions Re-verified since Sep 15, 2016, no change to tracked fieldsv3-v6
  4. Minor Study description expanded, about 12 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Long term follow-up of patients with chronic lymphocytic leukemia (CLL), B-prolymphocytic leukemia (B-PLL), T-cell prolymphocytic leukemia (T-PLL), Small lymphocytic lymphoma (SLL), T/Natural Killer large granular lymphocyte leukemia (T or NK-LGL), Hairy cell leukemia (HCL) and Richter's transformation
Trial Details
NCT Number NCT02863692
Lead Sponsor German CLL Study Group
Conditions
(from sponsor)
CLL, SLL, HCL, Richter´s Transformation, Leukemia, Prolymphocytic, B-Cell, Leukemia, Prolymphocytic, T-Cell, T-LGL Leukemia, NK-LGL Leukemia
Related terms Leukemia, Large Granular Lymphocytic, Leukemia, Prolymphocytic, B-Cell, Leukemia, Prolymphocytic, T-Cell
Enrollment 8,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov